Trial Profile
A retrospective cohort study evaluating adherence of adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Crohn's disease; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 03 Jan 2018 New trial record
- 22 Dec 2017 Results published in the British Journal of Clinical Pharmacology